Nitric Oxide Prevents Glioblastoma Stem Cells’ Expansion and Induces Temozolomide Sensitization

Glioblastoma multiforme (GBM) has high mortality and recurrence rates. Malignancy resilience is ascribed to Glioblastoma Stem Cells (GSCs), which are resistant to Temozolomide (TMZ), the gold standard for GBM post-surgical treatment. However, Nitric Oxide (NO) has demonstrated anti-cancer efficacy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvatori, Luisa, Malatesta, Silvia, Illi, Barbara, Somma, Maria Patrizia, Fionda, Cinzia, Stabile, Helena, Fontanella, Rosaria Anna, Gaetano, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379318/
https://www.ncbi.nlm.nih.gov/pubmed/37511047
http://dx.doi.org/10.3390/ijms241411286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379318/
https://www.ncbi.nlm.nih.gov/pubmed/37511047
http://dx.doi.org/10.3390/ijms241411286

Ejemplares similares